New techniques that might allow magnetic resonance imaging (MRI), to be used to give doctors subtle information about a tumour’s physiology and how it reacts to drug therapy are being developed.
The work is being carried out by doctors and medical physicists at the University of Aberdeen, with funding from the Swindon based Engineering and Physical Sciences Research Council.
Doctors treating cancerous tumours with drugs need to know quickly if the drug is having the desired effect to enable them to re-consider their strategy if a drug is ineffective. One of the current ways of rapidly assessing a tumour’s response to chemotherapy is by using positron emission tomography (PET). However, this is a costly procedure, which is not routinely available.
Jane Reck | Alpha Galileo
Nanoparticles as a Solution against Antibiotic Resistance?
15.12.2017 | Friedrich-Schiller-Universität Jena
Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
15.12.2017 | Power and Electrical Engineering
15.12.2017 | Materials Sciences
15.12.2017 | Life Sciences